Advertisement

Effects of Human Milk Growth Factor on Gastric and Duodenal Mucus Formation

  • S. Dai
  • M. Klagsbrun
  • C. W. Ogle
  • Y. Shing

Abstract

A polypeptide growth factor has been isolated from human milk, and designated human milk growth factor III (1–3). It is chemically related to epidermal growth factor-urogastrone, having a molecular weight of about 6,000 and an isoelectric point of about 4.5 (1–3). EGF-urogastrone is a potent mitogen for a variety of cells (4) and is known to stimulate the growth and maturation of the intestinal mucosa (5, 6). The detection and isolation of epidermal growth factor (EGF) in human milk have also been reported by several other laboratories (7,8,9,10). Besides being a mitogen, EGF-urogastrone is an inhibitor of gastric acid secretion (11) and has been used to promote healing of ulcers (12). Thus, it is conceivable that human milk grcwth factor III (HMGF III) may also have urogastrone-like effects on the gastrointestinal tract. In a previous study, we demonstrated that HMGF III was capable of dose-dependently protecting mice against the formation of duodenal ulcers induced by cysteamine (13). These results are in agreement with those reported by Kirkegaard et al (14) that EGF significantly inhibits the formation of cysteamine-induced duodenal ulcer in the rat. However, the mechanisms remain unclear. It has been reported that cysteamine causes a long-lasting hypersecretion of gastric acid (15) and inhibits secretion of alkaline mucus from duodenal Brunner’s glands (16). Therefore, it is possible that HMGF III could have exerted its anti-ulcer effects in mice by altering gastric acid and/or duodenal mucus synthesis in a pattern opposite to that evoked by cysteamine. In order to clarify the mechanisms of the anti-ulcer actions of HMGF III, the present study examines its effects on gastric acid secretion and mucus formation in the mouse stomach and duodenum.

Keywords

Duodenal Ulcer Human Milk Gastric Acid Secretion Intragastric Administration Atropine Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Y.W. Shing and M. Klagsbrun, Human and bovine milk contain different sets of grcwth factors, Endocrinology 115:273 (1984).CrossRefGoogle Scholar
  2. 2.
    Y.W. Shing and M. Klagsbrun, Isolation of growth factors from human milk, in: “Methods in Molecular and Cellular Biology”, vol. 1, pp. 159–179, G. Sato, D. Sirbasku, and D. Barnes, eds., Alan R. Liss, New York (1984).Google Scholar
  3. 3.
    M. Klagsbrun and Y.W. Shing, Growth promoting factors in human and bovine milk, in: “Grcwth and Maturation Factors”, vol. 2, pp. 161–192, G. Guroff, ed., John Wiley &Sons, New York (1984).Google Scholar
  4. 4.
    G. Carpenter and S. Cohen, Epidermal growth factor, Ann Rev Biochem 48:139 (1979).CrossRefGoogle Scholar
  5. 5.
    C. Malo and D. Ménard, Influence of epidermal growth factor on the development of suckling mouse intestinal mucosa, Gastroenterology 83:28 (1982).Google Scholar
  6. 6.
    R. Calvert, J.F. Beaulieu, and D. Ménard, Epidermal grcwth factor (EGF) accelerates the maturation of fetal mouse intestinal mucosa in utero, Experientia 38:1096 (1982).CrossRefGoogle Scholar
  7. 7.
    R.H. Starkey and D.N. Qrth, Radioimmunoassay of human epidermal growth factor (urogastrone), J Clin Endocrinol Metab 45:1144 (1977).CrossRefGoogle Scholar
  8. 8.
    G. Carpenter, Epidermal grcwth factor is a major growth-promoting agent in human milk. Science 210:198 (1980).CrossRefGoogle Scholar
  9. 9.
    P.E. Petrides, M. Hosang, E. Shooter, F.S. Esch, and P. Böhlen. Isolation and characterization of epidermal growth factor fron human milk, FEBS Letters 187:89 (1985).CrossRefGoogle Scholar
  10. 10.
    L.C. Read, L. Summer, S.M. Gale, C. George-Nascimento, F.J. Ballard, and J.C. Wallace, Properties of synthetic-gene recombinant human epidermal growth factor: comparison with the natural grcwth factor from human urine and milk, J. Endocrinology 109:245 (1986).CrossRefGoogle Scholar
  11. 11.
    J.M. Bower, R. Camble, H. Gregory, E.L. Gerring, and I.R. Willshire, The inhibition of gastric acid secretion by epidermal grcwth factor, Experientia 31:825 (1975).CrossRefGoogle Scholar
  12. 12.
    H. Gregory, J.M. Bower, and I.R. Willshire, Urogastrone and epidermal growth factor, in: “Growth Factors”, pp. 75–84, K.W. Kistrup, J.H. Nielsen, eds., Pergamon, Oxford (1979).Google Scholar
  13. 13.
    S. Dai, M. Klagsbrun, and Y.W. Shing, Human milk-derived growth factor prevents duodenal ulcer formation, Pediatric Res 19:916 (1985).CrossRefGoogle Scholar
  14. 14.
    P. Kirkegaard, P. Skov Olsen, S.S. Poulsen, and E. Nexø, Epidermal growth factor inhibits cysteamine-induced duodenal ulcers, Gastroenterology 85;1277 (1983).Google Scholar
  15. 15.
    W.G. Groves, J.H. Schlosser, and F.D. Mead, Acid hypersecretion and duodenal ulcers produced by cysteamine in rats, Res Commun Chem Pathol Pharmacol 9:523 (1974).Google Scholar
  16. 16.
    P. Kirkegaard, S.S. Poulsen, C. Halse, F.B. Loud, P. Skov Olsen, and J. Christiansen, The effect of cysteamine on the Brunner gland secretion in the rat, Scand J Gastroenterol 16:93 (1981).Google Scholar
  17. 17.
    H. Shay, D.C.H. Sun, M. Gruenstein, A quantitative method for measuring spontaneous gastric secretion in the rat, Gastroenterology 26:906 (1954).Google Scholar
  18. 18.
    S.J. Corne, S.M. Morrissey, and R.J. Woods, A method for the quantitative estimation of gastric barrier mucus, J Physiol (Lond) 242:116 (1974).Google Scholar
  19. 19.
    D.B. Norris, T.J. Rising, and T.P. Wood, In vitro measurement of gastric mucus synthesis by a dye binding technique, Br J Pharmacol 80:581 (1983).CrossRefGoogle Scholar
  20. 20.
    R.M. Pinder, R.N. Brogden, P.R. Sawyer, T.M. Speight, R. Spencer, and G.S. Avery, Carbenoxolone: A review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease, Drugs 11:245 (1983).CrossRefGoogle Scholar
  21. 21.
    M.D. Hollenberg, Epidermal growth factor-urogastrone, a polypeptide acquiring hormonal status, Vitam Horm 37:69 (1979).CrossRefGoogle Scholar
  22. 22.
    S.J. Konturek, T. Brzozowski, I. Piastucki, A. Dembinski, T. Radecki, A. Dembinska-Kiec, A. Zmuda, and H. Gregory, Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor, Gut 22:927 (1981).CrossRefGoogle Scholar
  23. 23.
    P. Skov Olsen, S.S. Poulsen, K. Therkelsen, and E. Nexø, Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats, Gastroenterology 90:911 (1986).Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • S. Dai
    • 1
  • M. Klagsbrun
    • 1
    • 2
  • C. W. Ogle
    • 1
  • Y. Shing
    • 1
    • 2
  1. 1.Department of Pharmacology, Faculty of MedicineUniversity of Hong KongHong Kong
  2. 2.Departments of Biological Chemistry and SurgeryHarvard Medical School and The Children’s HospitalBostonUSA

Personalised recommendations